Scot Sweet Study (Interaction of a Non-nutritive Sweetener With a High-fibre Weight Loss Diet) (SSS)

January 6, 2025 updated by: University of Aberdeen

Healthy Diets for a Healthy Weight: Exploring Physiological Mechanisms Related to Dietary Fibre and Non-Nutritive Sweeteners

The investigators present a weight loss diet intervention study, to be conducted as a within-subject design, with all food and beverages provided, to assess interaction of non-nutritive sweetener (sucralose) with a high-fibre weight loss diet, on markers of gut health in humans. This study will allow assessment of the effects of a non-nutritive sweetener (sucralose) with a high-fibre (soluble fibre, fructo-oligosaccharides, FOS) diet on metabolic health and activity and composition of gut microbiota, by a controlled human diet intervention study. The investigators propose to recruit participants living with obesity, with a poor diet quality (moderate habitual fibre intake) to additionally address diet inequalities in the research approach, and this will also allow examine the time-course of adaptation of the gut microbiome (measured in faecal samples). The investigators will also assess changes in free-living glycaemic control with addition of dietary fibre and bio-markers of health.

Study Overview

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aberdeen, United Kingdom, AB25 2ZD
        • Rowett Institute, University of Aberdeen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • healthy but overweight/obese (BMI 28-40kg/m2) males and females (postmenopausal, using the oral contraceptive pill or some form of hormonal contraceptive)
  • moderate habitual fibre intake (18-23g/day)

Exclusion Criteria:

Medication exclusion criteria:

  • antibiotic use (within the past 3 months due to impact on gut microbiota)
  • anti-depressants (current)
  • smoking or vaping
  • weight loss medication

Medical exclusion criteria:

  • Females who are planning to be pregnant, are pregnant or are breastfeeding
  • Anyone with food allergies, self-reported food sensitivity or intolerance
  • Anyone with coeliac disease or gluten intolerance
  • Anyone taking medication which may affect their appetite
  • Anyone with an eating disorder
  • Anyone with diabetes
  • Anyone with a gastrointestinal disorder, kidney disease, liver disease or gout
  • Anyone suffering from a psychiatric disorder or any type of substance abuse
  • Anyone suffering from unregulated thyroid disease

Other exclusion criteria:

  • Anyone following a vegetarian or vegan diet
  • Anyone following a current weight loss programme (that may be affecting lifestyle, physical activity & diet) or undergone gastric band/reduction surgery
  • Anyone with unsuitable veins for blood sampling
  • Anyone who is unable to fluently speak, read and understand English
  • Anyone who is unable to comply to an alcohol-free diet for 6 weeks

Current sweetener consumption will not be an exclusion criteria as the Phase 1 - CTRL and Phase 2 - HF WL diets will provide enough of a washout (4 weeks) before the Phase 3 diets containing sucralose are consumed. Participants who do habitually consume sweeteners will be asked not to use them during the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Control-High Fibre Weight Loss-High Fibre Non-Nutritive Sweetener Weight Loss: CTRL-HF WL-HF-NNS WL
  • Phase 1 CTRL: Control diet with moderate fibre consumption for 14days.
  • Phase 2 HF WL: High Fibre Weight Loss meal consumption for 14days.
  • Phase 3 HF-NNS WL: High Fibre and Non-Nutritive Sweetener Weight Loss meal consumption for 14days.
Control diet (30% Fat, 15% Protein, 55% Carbohydrate, Fibre rising from 10 to 16g/d). Fed to energy balance (1.5 x Resting Metabolic Rate, RMR).
Other Names:
  • CTRL
High Fibre Weight Loss diet (30% Fat, 15% Protein, 55% Carbohydrate). Fed to energy deficit (100% RMR). The quantity of fructo-oligosaccharides (FOS) will be fixed at 20g/day for all kcal levels with additional fibre coming from the diet provided. The FOS will be split over breakfast, lunch and dinner in drinks/yoghurts which will be compulsory to consume.
Other Names:
  • HF WL
High Fibre and Non-Nutritive Sweetener Weight Loss diet (30% Fat, 15% Protein, 55% Carbohydrate). Fed to energy deficit (100% RMR). The quantity of fructo-oligosaccharides (FOS) and non-nutritive sweetener (sucralose) will be fixed at 20g/day and 30mg/day respectively for all kcal levels with additional fibre coming from the diet provided. The FOS and sucralose will be split over breakfast, lunch and dinner in drinks/yoghurts which will be compulsory to consume.
Other Names:
  • HF-NNS WL

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in gut metabolites (from faecal samples) in response to dietary fibre and non-nutritive sweetener
Time Frame: At baseline and end of each arm (study days 1, 15, 29 and 43)
Measured by changes in faecal short chain fatty acids concentrations
At baseline and end of each arm (study days 1, 15, 29 and 43)
Change in gut microbiome composition (from faecal samples) in response to dietary fibre and non-nutritive sweetener
Time Frame: At baseline and end of each arm (study days 1, 15, 29 and 43)
Measured by changes in bacterial 16S ribosomal ribonucleic acid gene sequencing; 16S rRNA
At baseline and end of each arm (study days 1, 15, 29 and 43)
Change in gut metabolite production (from faecal samples) in response to dietary fibre and non-nutritive sweetener
Time Frame: At baseline and end of each arm (study days 1, 15, 29 and 43)
Measured by changes in calprotectin concentrations
At baseline and end of each arm (study days 1, 15, 29 and 43)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in free-living glycaemic control in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
measured using continuous glucose monitoring (CGM)
every day of study diets (42days)
Change in glycaemic control in response to dietary fibre and non-nutritive sweetener
Time Frame: At baseline and end of each arm (study days 1, 15, 29 and 43)
measured by changes in fasted plasma glucose and insulin
At baseline and end of each arm (study days 1, 15, 29 and 43)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Height
Time Frame: At screening visit only
measured in metres
At screening visit only
Change in concentration of blood metabolites in response to dietary fibre and non-nutritive sweetener
Time Frame: At baseline and end of each arm (study days 1, 15, 29 and 43)
measured by changes in fasted plasma short chain fatty acid (SCFA) concentrations
At baseline and end of each arm (study days 1, 15, 29 and 43)
Change in concentration of gut hormones in response to dietary fibre and non-nutritive sweetener
Time Frame: At baseline and end of each arm (study days 1, 15, 29 and 43)
measured by changes in fasted plasma ghrelin, GLP-1 and peptide YY (PYY) concentrations
At baseline and end of each arm (study days 1, 15, 29 and 43)
Change in lipid profile in response to dietary fibre and non-nutritive sweetener
Time Frame: At baseline and end of each arm (study days 1, 15, 29 and 43)
measured by changes in fasted plasma lipid profile (Total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides and non-esterified fatty acids (NEFA)
At baseline and end of each arm (study days 1, 15, 29 and 43)
Change in lipid ratios in response to dietary fibre and non-nutritive sweetener
Time Frame: At baseline and end of each arm (study days 1, 15, 29 and 43)
Total cholesterol, HDL-cholesterol and LDL-cholesterol measures will be combined to report TC to HDL and LDL to HDL ratios.
At baseline and end of each arm (study days 1, 15, 29 and 43)
Change in concentration of urinary metabolites in response to dietary fibre and non-nutritive sweetener
Time Frame: At baseline and end of each arm (study days 1, 15, 29 and 43)
changes in urinary metabolite concentrations measured by metabolomics
At baseline and end of each arm (study days 1, 15, 29 and 43)
Change in body weight in response to dietary fibre and non-nutritive sweetener
Time Frame: At screening and 3 times a week on each arm (20 occasions from date of screening up to study day 43)
measured as weight in kilograms
At screening and 3 times a week on each arm (20 occasions from date of screening up to study day 43)
Change in Body Mass Index (BMI) in response to dietary fibre and non-nutritive sweetener
Time Frame: At screening and 3 times a week on each arm (20 occasions from date of screening up to study day 43)
weight and height measures will be combined to report BMI in kg/m^2
At screening and 3 times a week on each arm (20 occasions from date of screening up to study day 43)
Change in daily nausea symptoms in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
measured daily, at end of day, using questionnaires. Question presented as a Likert scale 'Have you experienced nausea today?', scored as 0 - no more symptoms than usual, 1 - slightly more symptoms than usual, 2 - noticeably more symptoms than usual, 3 - considerably more symptoms than usual.
every day of study diets (42days)
Change in daily bloating symptoms in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
measured daily, at end of day, using questionnaires. Question presented as a Likert scale 'Have you experienced bloating today?', scored as 0 - no more symptoms than usual, 1 - slightly more symptoms than usual, 2 - noticeably more symptoms than usual, 3 - considerably more symptoms than usual.
every day of study diets (42days)
Change in daily flatulence symptoms in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
measured daily, at end of day, using questionnaires. Question presented as a Likert scale 'Have you experienced flatulence today?', scored as 0 - no more symptoms than usual, 1 - slightly more symptoms than usual, 2 - noticeably more symptoms than usual, 3 - considerably more symptoms than usual.
every day of study diets (42days)
Change in daily abdominal cramp symptoms in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
measured daily, at end of day, using questionnaires. Question presented as a Likert scale 'Have you experienced abdominal cramps today?', scored as 0 - no more symptoms than usual, 1 - slightly more symptoms than usual, 2 - noticeably more symptoms than usual, 3 - considerably more symptoms than usual.
every day of study diets (42days)
Change in daily intestinal rumble symptoms in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
measured daily, at end of day, using questionnaires. Question presented as a Likert scale 'Have you experienced rumbles today? (intestinal sounds)', scored as 0 - no more symptoms than usual, 1 - slightly more symptoms than usual, 2 - noticeably more symptoms than usual, 3 - considerably more symptoms than usual.
every day of study diets (42days)
Change in daily diarrhoea symptoms in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
measured daily, at end of day, using questionnaires. Question presented as a Likert scale 'Have you experienced diarrhoea today?', scored as 0 - no more symptoms than usual, 1 - slightly more symptoms than usual, 2 - noticeably more symptoms than usual, 3 - considerably more symptoms than usual.
every day of study diets (42days)
Change in daily constipation symptoms in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
measured daily, at end of day, using questionnaires. Question presented as a Likert scale 'Have you experienced constipation today?', scored as 0 - no more symptoms than usual, 1 - slightly more symptoms than usual, 2 - noticeably more symptoms than usual, 3 - considerably more symptoms than usual.
every day of study diets (42days)
Change in daily bowel movements in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
measured daily, at end of day, using questionnaires. Question presented as a scale 'How many bowel movements have you had today?', scored as 0, 1, 2, 3 or >3.
every day of study diets (42days)
Change in daily hunger rating in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
measured daily, at end of day, using questionnaires. Question presented as a visual analogue scale 'How hungry have you felt today?', scored from 0 (Generally not at all hungry) to 100 (Generally as hungry as I've ever felt).
every day of study diets (42days)
Change in daily fullness rating in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
measured daily, at end of day, using questionnaires. Question presented as a visual analogue scale 'How full have you felt today?', scored from 0 (Generally not at all full) to 100 (Generally as full as I've ever felt).
every day of study diets (42days)
Change in daily desire to eat rating in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
measured daily, at end of day, using questionnaires. Question presented as a visual analogue scale 'How strong has your desire to eat been today?', scored from 0 (Very weak) to 100 (Very strong).
every day of study diets (42days)
Change in retrospective food consumption rating in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
measured daily, at end of day, using questionnaires. Question presented as a visual analogue scale 'How much do you feel you could have eaten today?', scored from 0 (Nothing at all) to 100 (A large amount).
every day of study diets (42days)
Change in appetite in response to dietary fibre and non-nutritive sweetener
Time Frame: every day of study diets (42days)
Mean of hunger, fullness, desire to eat and retrospective consumption ratings will be combined to report an overall appetite score (from 0 to 100)
every day of study diets (42days)
Change in food intake
Time Frame: at screening (7days) and every day of study diets (42days)
measured using weighed intake records
at screening (7days) and every day of study diets (42days)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alexandra Johnstone, Prof, Rowett Institute, University of Aberdeen
  • Principal Investigator: Alexander Ross, Dr, Rowett Institute, University of Aberdeen

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 12, 2023

Primary Completion (Actual)

December 16, 2024

Study Completion (Actual)

December 16, 2024

Study Registration Dates

First Submitted

May 17, 2023

First Submitted That Met QC Criteria

May 26, 2023

First Posted (Actual)

June 7, 2023

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 6, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 814

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Appetitive Behavior

Clinical Trials on Phase 1 Control

Subscribe